These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9289719)

  • 1. [Circulating immune complexes as markers of Hodgkin's disease activity].
    Urbaniak-Kujda D
    Pol Tyg Lek; 1996 May; 51(19-22):303-4. PubMed ID: 9289719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
    Amlot PL; Pussell B; Slaney JM; Williams BD
    Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes in the serum of patients with Hodgkin's disease].
    Berényi E; Kávai M; Pálkövi E; Szegedi G
    Orv Hetil; 1979 Jan; 120(2):79-82. PubMed ID: 760038
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes in patients with malignant diseases].
    Smolen JS; Menzel EJ; Aiginger P; Scherak O; Knapp W; Kühböck J
    Acta Med Austriaca Suppl; 1979; 6():311-3. PubMed ID: 162423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
    Dziewulska-Bokiniec A; Sztaba-Kania M
    Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical immune complex nephritis in patients with Hodgkin's disease.
    Sutherland JC; Markham RV; Ramsey HE; Mardiney MR
    Cancer Res; 1974 May; 34(5):1179-81. PubMed ID: 4276372
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating immune complexes and symptoms in Hodgkin's disease.
    Amlot PL; Slaney JM; Williams BD
    Lancet; 1976 Feb; 1(7957):449-51. PubMed ID: 55719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease associated with unusual immunological manifestations.
    Miró JM; Gatell JM; Llebaria C; Montserrat E; Garcia SanMiguel J
    Nouv Rev Fr Hematol (1978); 1982; 24(2):81-3. PubMed ID: 6213933
    [No Abstract]   [Full Text] [Related]  

  • 12. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM; Boĭchenko PK; Peresadin NA
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Immune complexes in Hodgkin's disease.
    Kávai M; Berényi E; Pálkovi E; Szegedi G
    Lancet; 1976 Jun; 1(7971):1249. PubMed ID: 58301
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
    Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
    J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of immune complexes with Hodgkin's disease tissue cultures.
    Long JC; Dvorak AM; Quay SC; Stamatos C
    J Natl Cancer Inst; 1981 Jul; 67(1):3. PubMed ID: 6942193
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating immune complexes in Hodgkin's disease.
    Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
    Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
    Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
    J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of circulating immune complexes (CIC) in patients with malignant salivary gland tumors.
    Lotfy M; Yassin S; Ezz M
    Egypt Dent J; 1993 Oct; 39(4):547-8. PubMed ID: 9588121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.